MedPath

Study to explore the use of potential biomarkers of Gcase enzyme activation in healthy subjects and patients with Parkinson's Disease with and without a mutation in the GBAgene

Conditions
Parkinson's DiseaseZiekte van Parkinson
Registration Number
NL-OMON26026
Lead Sponsor
CHDR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

Group 1, Inclusion criteria;

1. Signed informed consent prior to any study-mandated procedure.

Exclusion Criteria

Group 1, exclusion criteria;

1. Any recent (within 7 days) infectious disease.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. GCase activity in whole-blood<br /><br>2. GCase activity in isolated PBMCs<br /><br>3. GCase protein in PBMCs<br /><br>4. GluCer in PBMCs and plasma - Potentially other substrates / products in the same metabolic pathway<br />
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath